Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRX✓SelectedUSD · RRXGSK vs RRX performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs RRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,646.5%
RRX return
+3,935.9%
Excess return
-2,289.4%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioRRXExcessAlpha
1D-1.6%-3.1%+1.5%-1.1%
7D-4.7%-9.3%+4.6%-3.3%
30D-4.7%+5.0%-9.7%-5.8%
3M-8.8%-3.2%-5.6%-8.9%
6M-4.6%-11.8%+7.2%-4.3%
YTD+1.0%+17.4%-16.4%-3.9%
1Y+6.9%+26.1%-19.2%+0.5%
3Y+52.5%+45.2%+7.4%+35.8%
5Y+40.3%0.0%+40.2%+30.0%
10Y+99.0%+179.5%-80.6%+48.6%
All+1,646.5%+3,935.9%-2,289.4%+831.5%

Cumulative growth

Daily Returns

Daily percentage return beside RRX.

Daily Out/Under-Performance

Portfolio return minus RRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded RRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling